Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 09:40 am Purchase | 13G | TAYSHA GENE THERAPIES INC TSHA | Avoro Capital Advisors LLC | 23,094,444 9.990% | 23,094,444 (New Position) | View |
| 2024-11-14 09:39 am Purchase | 13G | TOURMALINE BIO INC TRML | Avoro Capital Advisors LLC | 2,222,222 8.700% | 2,222,222 (New Position) | View |
| 2024-11-14 09:39 am Purchase | 13G | Avidity Biosciences Inc. RNA | Avoro Capital Advisors LLC | 9,935,792 8.300% | 9,935,792 (New Position) | View |
| 2024-11-14 09:38 am Purchase | 13G | ARROWHEAD PHARMACEUTICALS INC. ARWR | Avoro Capital Advisors LLC | 8,888,888 7.200% | 8,888,888 (New Position) | View |
| 2024-11-14 09:37 am Purchase | 13G | OCULAR THERAPEUTIX INC OCUL | Avoro Capital Advisors LLC | 12,714,874 7.900% | 12,714,874 (New Position) | View |
| 2024-11-14 09:36 am Purchase | 13G | SOLENO THERAPEUTICS INC PA SLNO | Avoro Capital Advisors LLC | 2,181,000 5.600% | 2,181,000 (New Position) | View |
| 2024-11-14 09:35 am Purchase | 13G | Vera Therapeutics Inc. VERA | Avoro Capital Advisors LLC | 4,309,590 7.900% | 4,309,590 (New Position) | View |
| 2024-11-14 09:35 am Sale | 13G | Spyre Therapeutics Inc. SYRE | Avoro Capital Advisors LLC | 885,059 1.700% | -954,079 (-51.88%) | View |
| 2024-11-14 09:34 am Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | Avoro Capital Advisors LLC | 0 0.000% | -3,150,000 (Position Closed) | View |
| 2024-11-14 09:33 am Sale | 13G | STRUCTURE THERAPEUTICS INC SPO GPCR | Avoro Capital Advisors LLC | 0 0.000% | -6,999,999 (Position Closed) | View |
| 2024-11-14 09:32 am Sale | 13G | Verrica Pharmaceuticals Inc. VRCA | Avoro Capital Advisors LLC | 0 0.000% | -6,583,332 (Position Closed) | View |
| 2024-11-14 09:31 am Sale | 13G | AMICUS THERAPEUTICS INC. FOLD | Avoro Capital Advisors LLC | 23,175,000 7.800% | -4,225,000 (-15.42%) | View |
| 2024-11-14 09:31 am Purchase | 13G | Ascendis Pharma A/S ASND | Avoro Capital Advisors LLC | 4,988,888 8.200% | 1,233,333 (+32.84%) | View |
| 2024-11-14 09:30 am Purchase | 13G | KYMERA THERAPEUTICS INC KYMR | Avoro Capital Advisors LLC | 7,750,000 9.990% | 3,975,000 (+105.30%) | View |
| 2024-04-23 6:22 pm Sale | 13G | Spyre Therapeutics Inc. SYRE | Avoro Capital Advisors LLC | 1,839,138 5.100% | -286,459 (-13.48%) | View |
| 2024-02-14 09:25 am Purchase | 13G | KRYSTAL BIOTECH INC KRYS | Avoro Capital Advisors LLC | 2,565,555 9.100% | 1,155,555 (+81.95%) | View |
| 2024-02-14 09:23 am Purchase | 13G | Apellis Pharmaceuticals Inc. APLS | Avoro Capital Advisors LLC | 13,411,111 9.900% | 2,786,111 (+26.22%) | View |
| 2024-02-14 09:22 am Purchase | 13G | AMICUS THERAPEUTICS INC. FOLD | Avoro Capital Advisors LLC | 27,400,000 9.300% | 600,000 (+2.24%) | View |
| 2024-02-14 09:21 am Purchase | 13G | MADRIGAL PHARMACEUTICALS INC. MDGL | Avoro Capital Advisors LLC | 2,288,888 9.900% | 628,888 (+37.88%) | View |
| 2024-02-14 09:20 am Sale | 13G | Mersana Therapeutics Inc. MRSN | Avoro Capital Advisors LLC | 0 0.000% | -7,550,000 (Position Closed) | View |